← Back to Patent Explorer
US4109079A Expired / Lapsed US ⏱️ 0.0 years remaining

Stabilized s-adenosyl-l-methionine preparations

Assignee: Yamasa Shoyu KK
•
Filing: 1976-10-14
•
Granted: 1978-08-22
•
Expires: 1996-10-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A stabilized dry S-adenosyl-L-methionine preparation is obtained by incorporating about 1 - 10 parts by weight of lithium in the form of a salt with 100 parts by weight of S-adenosyl-L-methionine or a low-toxicity salt thereof. According to the invention, instability of S-adenosyl-L-methionine or a salt thereof is substantially eliminated. The stabilized dry preparation is very useful as medical drugs and reagents for biochemical research.

Inventors

  • 👤 Toshihisa Kawahara
  • 👤 Goro Motoki
  • 👤 Kazuo Uchida
  • 👤 Hiroshi Yoshino

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-10 01:28
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16; A; A61; A61K; A61K47/00; A61K47/02

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 49 words
A stabilized dry S-adenosyl-L-methionine preparation which comprises S-adenosyl-L-methionine or a pharmaceutically acceptable salt thereof and an effective amount of a lithium salt which is pharmaceutically acceptable and is soluble in an acidic solution of the S-adenosyl-L-methionine or a pharmaceutically acceptable salt thereof and does not make the solution alkaline.
Claim 2
Dependent Claim 49 words
A stabilized dry S-adenosyl-L-methionine preparation which comprises S-adenosyl-L-methionine or a pharmaceutically acceptable salt thereof and an effective amount of a lithium salt which is pharmaceutically acceptable and is soluble in an acidic solution of the S-adenosyl-L-methionine or a pharmaceutically acceptable salt thereof and does not make the solution alkaline.
Claim 3
Dependent Claim 21 words
The preparation as set forth in claim 1, in which the preparation contains not more than 3% by weight of moisture.
Claim 4
Dependent Claim 29 words
The preparation as set forth in claim 1, in which the S-adenosyl-L-methionine salt is selected from the group consisting of the hydrochloride, sulfate, iodide, bromide and Reinecke's salt thereof.
Claim 5
Dependent Claim 47 words
The preparation as set forth in claim 1, in which the lithium salt is selected from the group consisting of lithium chloride, lithium bromide, lithium iodide, lithium sulfate, lithium nitrate, lithium phosphate, lithium borate, lithium carbonate, lithium formate, lithium acetate, lighium citrate, lithium succinate and lithium benzoate.
Claim 6
Dependent Claim 70 words
The preparation as set forth in claim 1, in which the preparation comprises S-adenosyl-L-methionine or a pharmaceutically acceptable salt thereof and a lithium salt which is pharmaceutically acceptable and is soluble in an acidic solution of the S-adenosyl-L-methionine or a pharmaceutically acceptable salt thereof and does not make the solution alkaline, added thereto in an amount of about 1 to 10% by weight as lithium of the amount of S-adenosyl-L-methionine.
Claim 7
Dependent Claim 21 words
The preparation as set forth in claim 5, in which the preparation contains not more than 2% by weight of moisture.
Claim 8
Dependent Claim 29 words
The preparation as set forth in claim 5, in which the S-adenosyl-L-methionine salt is selected from the group consisting of the hydrochloride, sulfate, iodide, bromide and Reinecke's salt thereof.
Claim 9
Dependent Claim 45 words
The preparation as set forth in claim 5, in which the lithium salt is selected from the group consisting of lithium chloride, lithium bromide, lithium iodide, lithium sulfate, lithium nitrate, lithium borate, lithium carbonate, lithium formate, lithium acetate, lithium citrate, lithium succinate and lithium benzoate.
Claim 10
Dependent Claim 16 words
The preparation as set forth in claim 5, in which the S-adenosyl-L-methionine salt is hydrochloride thereof.
Claim 11
Dependent Claim 17 words
The preparation as set forth in claim 9, in which the lithium salt is a halide thereof.
Claim 12
Dependent Claim 25 words
The preparation according to claim 1 wherein the lithium salt is selected from the group consisting of chloride, bromide, sulfate, carbonate, acetate, citrate and succinate.
Claim 13
Dependent Claim 25 words
The preparation according to claim 5 wherein the lithium salt is selected from the group consisting of chloride, bromide, sulfate, carbonate, acetate, citrate and succinate.

References Cited (Backward Citations)

US2946781A Cited
US2969353A Cited
US3707536A Cited
US3893999A Cited
US3954726A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-08-21 1982-02-20 1982-08-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-08-21 1986-02-20 1986-08-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-08-21 1990-02-20 1990-08-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag